Showing 1-6 of 6 results for "".

• Recent Developments

  https://practicaldermatology.com/columns/recent-developments/recent-developments-37/23755/
  • Text

• DermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link

  https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/
  FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)
  • Video

• Perspective on Teledermatology's Present and Future

  https://practicaldermatology.com/topics/practice-management/perspective-on-teledermatologys-present-and-future/20378/
  A dermatologist shares her experience offering e-consults and describes how teledermatology can expand access to care.
  • Text

• Recent Developments

  https://practicaldermatology.com/columns/recent-developments/recent-developments-21/23421/
  • Text

• 2022 in Review

  https://practicaldermatology.com/topics/other-dermatology/2022-in-review/23833/
  The past year brought many new approvals and advances to dermatology for improved patient care.
  • Text
• Camille Lee
  https://practicaldermatology.com/profiles/camille-lee/jRx3kW/